Literature DB >> 26516283

Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling.

Alexandria M Palaferri Schieber1, Yujung Michelle Lee1, Max W Chang2, Mathias Leblanc3, Brett Collins3, Michael Downes3, Ronald M Evans4, Janelle S Ayres5.   

Abstract

Infections and inflammation can lead to cachexia and wasting of skeletal muscle and fat tissue by as yet poorly understood mechanisms. We observed that gut colonization of mice by a strain of Escherichia coli prevents wasting triggered by infections or physical damage to the intestine. During intestinal infection with the pathogen Salmonella Typhimurium or pneumonic infection with Burkholderia thailandensis, the presence of this E. coli did not alter changes in host metabolism, caloric uptake, or inflammation but instead sustained signaling of the insulin-like growth factor 1/phosphatidylinositol 3-kinase/AKT pathway in skeletal muscle, which is required for prevention of muscle wasting. This effect was dependent on engagement of the NLRC4 inflammasome. Therefore, this commensal promotes tolerance to diverse diseases.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26516283      PMCID: PMC4732872          DOI: 10.1126/science.aac6468

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  44 in total

Review 1.  Tolerance of infections.

Authors:  Janelle S Ayres; David S Schneider
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

Review 2.  Host-gut microbiota metabolic interactions.

Authors:  Jeremy K Nicholson; Elaine Holmes; James Kinross; Remy Burcelin; Glenn Gibson; Wei Jia; Sven Pettersson
Journal:  Science       Date:  2012-06-06       Impact factor: 47.728

Review 3.  The origins of cachexia in acute and chronic inflammatory diseases.

Authors:  Matthew J Delano; Lyle L Moldawer
Journal:  Nutr Clin Pract       Date:  2006-02       Impact factor: 3.080

4.  A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice.

Authors:  I Okayasu; S Hatakeyama; M Yamada; T Ohkusa; Y Inagaki; R Nakaya
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

5.  Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host.

Authors:  Manja Barthel; Siegfried Hapfelmeier; Leticia Quintanilla-Martínez; Marcus Kremer; Manfred Rohde; Michael Hogardt; Klaus Pfeffer; Holger Rüssmann; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

6.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.

Authors:  Jennifer M Sacheck; Akira Ohtsuka; S Christine McLary; Alfred L Goldberg
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-04-20       Impact factor: 4.310

Review 7.  Recognition of bacteria by inflammasomes.

Authors:  Jakob von Moltke; Janelle S Ayres; Eric M Kofoed; Joseph Chavarría-Smith; Russell E Vance
Journal:  Annu Rev Immunol       Date:  2012-11-26       Impact factor: 28.527

8.  Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota.

Authors:  Janelle S Ayres; Norver J Trinidad; Russell E Vance
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

9.  Why cachexia kills: examining the causality of poor outcomes in wasting conditions.

Authors:  Kamyar Kalantar-Zadeh; Connie Rhee; John J Sim; Peter Stenvinkel; Stefan D Anker; Csaba P Kovesdy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2013-06-08       Impact factor: 12.910

10.  Limited role for ASC and NLRP3 during in vivo Salmonella Typhimurium infection.

Authors:  Hanna K De Jong; Gavin C K W Koh; Miriam H P van Lieshout; Joris J T H Roelofs; Jaap T van Dissel; Tom van der Poll; W Joost Wiersinga
Journal:  BMC Immunol       Date:  2014-08-13       Impact factor: 3.615

View more
  69 in total

Review 1.  The Gut Microbiome: Connecting Spatial Organization to Function.

Authors:  Carolina Tropini; Kristen A Earle; Kerwyn Casey Huang; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2017-04-12       Impact factor: 21.023

Review 2.  Thermoregulation as a disease tolerance defense strategy.

Authors:  Alexandria M Palaferri Schieber; Janelle S Ayres
Journal:  Pathog Dis       Date:  2016-11-03       Impact factor: 3.166

Review 3.  Disease tolerance and immunity in host protection against infection.

Authors:  Miguel P Soares; Luis Teixeira; Luis F Moita
Journal:  Nat Rev Immunol       Date:  2017-01-03       Impact factor: 53.106

4.  The gut microbiota of critically ill patients: first steps in an unexplored world.

Authors:  Étienne Ruppé; Thiago Lisboa; François Barbier
Journal:  Intensive Care Med       Date:  2018-07-14       Impact factor: 17.440

Review 5.  Gut Microbiota and IGF-1.

Authors:  Jing Yan; Julia F Charles
Journal:  Calcif Tissue Int       Date:  2018-01-23       Impact factor: 4.333

6.  Antifungal Bacteria on Woodland Salamander Skin Exhibit High Taxonomic Diversity and Geographic Variability.

Authors:  Carly R Muletz-Wolz; Graziella V DiRenzo; Stephanie A Yarwood; Evan H Campbell Grant; Robert C Fleischer; Karen R Lips
Journal:  Appl Environ Microbiol       Date:  2017-04-17       Impact factor: 4.792

7.  Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-02-07

Review 8.  Disease tolerance: concept and mechanisms.

Authors:  J L McCarville; J S Ayres
Journal:  Curr Opin Immunol       Date:  2017-12-15       Impact factor: 7.486

Review 9.  Regulation of inflammation by microbiota interactions with the host.

Authors:  J Magarian Blander; Randy S Longman; Iliyan D Iliev; Gregory F Sonnenberg; David Artis
Journal:  Nat Immunol       Date:  2017-07-19       Impact factor: 25.606

10.  Gut microbiota induce IGF-1 and promote bone formation and growth.

Authors:  Jing Yan; Jeremy W Herzog; Kelly Tsang; Caitlin A Brennan; Maureen A Bower; Wendy S Garrett; Balfour R Sartor; Antonios O Aliprantis; Julia F Charles
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.